← All trials
NCT03823248
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2019
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 480
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- China Academy of Chinese Medical SciencesLead sponsor
- Jiangsu UniversityCollaborator
- Capital Medical UniversityCollaborator
- Guangdong Provincial Hospital of Traditional Chinese MedicineCollaborator
- Shanghai Yueyang Integrated Medicine HospitalCollaborator
- Wuhan Integrated Traditional Chinese and Western Medicine HospitalCollaborator
- Tianjin Medical UniversityCollaborator
- Hunan University of Traditional Chinese MedicineCollaborator
- Shaanxi University of Chinese MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.